Patients with macular edema who received a dexamethasone intravitreal implant experienced significantly improved best corrected visual acuity and central retinal thickness over a 1-year period, according to study.
The prospective, open-label, multicenter study included 71 patients with macular edema for less than 3 months. The primary endpoint was mean change from baseline in best corrected visual acuity (BCVA) at 6 months, and secondary was increase in BCVA of 15 letters or more at months 6 and 12.
Only 59 patients completed the 12-month study and 62 patients remained at the (Read more...)
Uncategorized